Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we see new data on a next-generation obesity candidate from Novo Nordisk and pages on the FDA’s website pulled down, including those centered on boosting clinical trial diversity. Also, the Sacklers and Purdue strike a $7.4 billion settlement in the long-standing opioids lawsuit, and more.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
